With all the "measles outbreaks" that brought national headlines earlier this year, and resulted in may states introducing legislation to force vaccinate the public and remove vaccine exemptions for school-age children, one thing the national corporate-sponsored "mainstream" media failed to report, is that the only vaccine available in the U.S. for measles has been involved in an 9-year long legal battle for fraud, due to Merck's own scientists who helped develop the vaccine becoming whistleblowers. First of all, there is no measles vaccine available in the U.S., only a 3 dose combination vaccine for mumps, measles and rubella (MMR), which is licensed to Merck. The mumps portion of the vaccine is what Merck's own scientists have claimed is fraudulent, and not effective. The only time the corporate media, which is heavily funded by the pharmaceutical industry, really covered the lawsuit was two years after it was originally filed back in 2010, when in 2012 a judge unsealed key documents. It is not surprising then that the CDC and other government health agencies are concentrating on cases of measles in the U.S. public, instead of outbreaks of mumps which far exceeds measles outbreaks, and happens primarily among the vaccinated population. Health Impact News has been following the Merck MMR fraud lawsuit for over 6 years now, and we exposed the hypocrisy of government health officials concentrating on measles outbreaks, even though mumps outbreaks are far more serious, earlier this year. Attorney Robert F. Kennedy, Jr. is now reporting that the 9-year-old long MMR fraud lawsuit may be coming to an end, and that U.S. Department of Health and Human Services officials are trying to get the FDA to approve the Glaxo Smith Kline (GSK) version of the MMR vaccine in the U.S. in case the judge rules against Merck. However, there is no evidence that GSK's version of the vaccine is any better.

Read full story...